Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 62.56 +0.19%   SPY: 132.27 +0.05%
Quote Spy TSRX NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


Trius Therapeutics (TSRX)

@ 4:00 PM
Click the portfolio to add TSRX:
Close [X]
+ Add TSRX to Portfolio
  
  Last Trade: $5.04 -0.01 (-0.20%)
  Volume: 110,585 82% of avg daily volume
       
  Avg Volume: 134,860
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 4.97 - 5.07
  Open: 5.01
  Previous Close: 5.05
  52-wk Range: 4.71 - 9.00
  Market Cap: 195.2M
  P/E: -10.5
  Div Yield: $0.00 (0.00%)
Indexes
2010 IPOs (+0.4%)
Biotechnology Stocks (+0.1%)
Spy TSRX

? Pro holders
? Member holders
? Items submitted
Additional TSRX resources



Customize Links
To see which Pros and tickerspy members own TSRX Sign up now
Latest TSRX Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

Trius Therapeutics Added to the NASDAQ Biotechnology Index
TSRX  
Linked by GlobeNewswire - May 14, 08:00AM from (www.globenewswire.com)
SAN DIEGO, May 14, 2012 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX), a biopharmaceutical company focused on  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
NASDAQ Changes Up Biotech Index Members & Weightings
CLDX  CBRX  CERS  BPAX  CRME  RPTP  DRRX  INFI  IBB  FOLD  JAZZ  OMER  CBPO  OREX  TSRX  PCRX  BBH  XBI  
Linked by 24/7 Wall St. - May 14, 07:59AM from (247wallst.com)
Index changes are generally speaking a fairly routine event. They can also create underlying moves in the companies added  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Trius to Present at the BioCentury Future Leaders Conference
TSRX  
Linked by GlobeNewswire - April 16, 08:00AM from (www.globenewswire.com)
SAN DIEGO, April 16, 2012 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX) announced today that Jeffrey Stein,  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Trius' Antibiotic Tedizolid Demonstrates High Efficacy in Patients With Cellulitis
TSRX  
Linked by GlobeNewswire - April 02, 07:00AM from (www.globenewswire.com)
SAN DIEGO, April 2, 2012 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX) announced today the results of a subgroup  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Trius Therapeutics Reports Fourth Quarter and Year End 2011 Financial Results
TSRX  
Linked by GlobeNewswire - March 13, 08:00AM from (www.globenewswire.com)
SAN DIEGO, March 13, 2012 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX), a biopharmaceutical company focused  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Trius to Present at Citi & RBC Investor Conferences
TSRX  
Linked by GlobeNewswire - February 23, 07:00AM from (www.globenewswire.com)
SAN DIEGO, Feb. 23, 2012 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX) announced today that Jeffrey Stein, Ph.D.,  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Trius Announces Issuance of Tedizolid Patent in China
TSRX  
Linked by GlobeNewswire - February 16, 07:00AM from (www.globenewswire.com)
SAN DIEGO, Feb. 16, 2012 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX) announced today the issuance of Patent  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Trius to Present at the BIO CEO & Investor Conference
TSRX  
Linked by GlobeNewswire - February 07, 04:01PM from (www.globenewswire.com)
SAN DIEGO, Feb. 7, 2012 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX) announced today that Jeffrey Stein, Ph.D.,  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Trius Therapeutics, Inc. Announces Exercise in Full of Underwriters' Option to Purchase Additional Shares for Common Stock Offering
TSRX  
Linked by GlobeNewswire - January 30, 07:00AM from (www.globenewswire.com)
SAN DIEGO, Jan. 30, 2012 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX) today announced that the underwriters  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Trius Therapeutics, Inc. Prices Public Offering of Common Stock
TSRX  
Linked by GlobeNewswire - January 26, 09:04AM from (www.globenewswire.com)
SAN DIEGO, Jan. 26, 2012 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX) today announced the pricing of an underwritten  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource